- L’Oreal Groupe unveiled technology at CES that will enable consumers to receive a personalized analysis of their skin to determine which products best suit their needs.
- L’Oreal Cell BioPrint is a tabletop device developed in partnership with Korean startup company NanoEnTek. It uses advanced proteomics – the study of how protein composition in the human body affects skin aging – to produce personalized skin analysis in five minutes.
- Developed as part of L’Oreal’s Longevity Integrative Science, L’Oreal’s Cell BioPrint is scheduled to pilot in Asia later this year.
Through its non-invasive process, which involves placing a facial tape strip into a buffer solution cartridge and the cartridge into the tabletop machine, the L’Oreal Cell BioPrint is designed to help take the guesswork out of skincare. According to a survey of 2,000 adults in the U.S. by OnePoll in conjunction with CeraVe, nearly 80% of consumers relied on trial and error to determine which products worked best for them. The average person reported trying seven different cleansers before finding one they love, according to the survey.
Information from the L’Oreal Cell BioPrint can help consumers calculate their skin’s biological age and then help provide personalized advice on how to slow down the appearance of aging. It can also help predict individual responsiveness to certain key ingredients in skincare products and help consumers begin taking a more proactive approach to skincare (such as determining if their skin is prone to dark spots or has larger pores).
“At L’Oréal, we’re always looking toward the future of beauty, blending cutting-edge discoveries with our long-standing beauty expertise,” said Barbara Lavernos, Deputy CEO in charge of Research, Innovation and Technology at L’Oréal Groupe, in a statement. “With the Cell BioPrint device, we offer people the ability to discover deeper insights about their skin through specific biomarkers and to proactively address the beauty and longevity of their skin.”
